Which statement about NSTEMI treatment is correct?

Which statement about NSTEMI treatment is correct?

• A. Fibrinolytics are not needed for NSTEMI.
• B. Fibrinolytics are the goal therapy for NSTEMI.
• C. Surgery is always required immediately for NSTEMI.
• D. No treatment is necessary for NSTEMI.

Answer: (A)

NSTEMI management focuses on preventing further clot formation and reducing myocardial oxygen demand, followed by early invasive evaluation rather than immediate clot-busting therapy. Fibrinolytics dissolve clots and are most beneficial when there is a full-thickness coronary occlusion causing ST-segment elevation, which is typical of STEMI. In NSTEMI, the coronary blockage is often not complete, and studies haven’t shown a mortality benefit from fibrinolysis; plus, the bleeding risk from fibrinolytics is a significant concern. Therefore, the preferred approach is antiplatelet therapy (aspirin plus a P2Y12 inhibitor), anticoagulation (such as heparin), nitrates for chest pain, beta-blockers, and high-intensity statin therapy, with plans for early coronary angiography and possible PCI based on risk. So fibrinolytics are not needed for NSTEMI.

NSTEMI management focuses on preventing further clot formation and reducing myocardial oxygen demand, followed by early invasive evaluation rather than immediate clot-busting therapy. Fibrinolytics dissolve clots and are most beneficial when there is a full-thickness coronary occlusion causing ST-segment elevation, which is typical of STEMI. In NSTEMI, the coronary blockage is often not complete, and studies haven’t shown a mortality benefit from fibrinolysis; plus, the bleeding risk from fibrinolytics is a significant concern. Therefore, the preferred approach is antiplatelet therapy (aspirin plus a P2Y12 inhibitor), anticoagulation (such as heparin), nitrates for chest pain, beta-blockers, and high-intensity statin therapy, with plans for early coronary angiography and possible PCI based on risk. So fibrinolytics are not needed for NSTEMI.